As part of his studies on Internal medicine, Philip A. Poole-Wilson frequently links adjacent subjects like Cancer. Philip A. Poole-Wilson conducted interdisciplinary study in his works that combined Cardiology and Endocrinology. He performs integrative Endocrinology and Cardiology research in his work. His multidisciplinary approach integrates Heart failure and Ejection fraction in his work. Philip A. Poole-Wilson integrates Ejection fraction with Heart failure in his research. In his research, he undertakes multidisciplinary study on Blood pressure and Heart rate. Heart rate and Blood pressure are two areas of study in which Philip A. Poole-Wilson engages in interdisciplinary research. Philip A. Poole-Wilson combines Myocardial infarction and Randomized controlled trial in his research. Philip A. Poole-Wilson connects Randomized controlled trial with Myocardial infarction in his study.
Internal medicine is closely attributed to Calcium in his study. His study brings together the fields of Heart failure and Cardiology. His Heart failure study frequently involves adjacent topics like Cardiology. Philip A. Poole-Wilson conducts interdisciplinary study in the fields of Blood pressure and Heart rate through his research. Philip A. Poole-Wilson combines Heart rate and Blood pressure in his research. He frequently studies issues relating to Contraction (grammar) and Endocrinology. His Contraction (grammar) study frequently draws connections to adjacent fields such as Endocrinology. He regularly links together related areas like Internal medicine in his Myocardial infarction studies.
Carvedilol, Natriuretic peptide, Ejection fraction, Brain natriuretic peptide and Cardiac function curve are inextricably linked to his Heart failure research. Ejection fraction is closely attributed to Cardiology in his study. He regularly links together related areas like Brain natriuretic peptide in his Cardiology studies. He combines Internal medicine and Psychiatry in his research. In his works, Philip A. Poole-Wilson performs multidisciplinary study on Psychiatry and Internal medicine. His study brings together the fields of Surgery and Randomized controlled trial. Surgery is closely attributed to Randomized controlled trial in his research. He applies his multidisciplinary studies on Myocardial infarction and Angina in his research. Philip A. Poole-Wilson performs multidisciplinary study on Angina and Coronary artery disease in his works.
The research on Natriuretic peptide and Ejection fraction is part of his Heart failure project. In his papers, Philip A. Poole-Wilson integrates diverse fields, such as Ejection fraction and Heart failure. Angina and Unstable angina are the subject areas of his Myocardial infarction study. Surgery is intertwined with Interventional cardiology, Mortality rate and Randomized controlled trial in his research. Philip A. Poole-Wilson combines Interventional cardiology and Coronary artery disease in his research. Philip A. Poole-Wilson undertakes multidisciplinary studies into Coronary artery disease and Unstable angina in his work. Mortality rate and Internal medicine are commonly linked in his work. His Internal medicine study frequently involves adjacent topics like Angina. Much of his study explores Randomized controlled trial relationship to Surgery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Wilson S. Colucci;Barry M. Massie;Philip A. Poole-Wilson.
ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).
Kenneth Dickstein;Alain Cohen-Solal;Gerasimos Filippatos;John J V McMurray.
European Journal of Heart Failure (2008)
Universal definition of myocardial infarction.
Kristian Thygesen;Joseph S. Alpert;Harvey D. White;Allan S. Jaffe.
European Heart Journal (2007)
Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II
Bertram Pitt;Philip A Poole-Wilson;Robert Segal;Felipe A Martinez.
The Lancet (2000)
Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial
Philip A. Poole-Wilson;Karl Swedberg;John G.F. Cleland;Andrea Di Lenarda.
The Lancet (2003)
The Seattle Heart Failure Model Prediction of Survival in Heart Failure
Wayne C. Levy;Dariush Mozaffarian;David T. Linker;Santosh C. Sutradhar.
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)
Marcus D. Flather;Marcelo C. Shibata;Andrew J.S. Coats;Dirk J. Van Veldhuisen.
European Heart Journal (2005)
Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency.
Stefan D. Anker;Josep Comin Colet;Gerasimos Filippatos;Ronnie Willenheimer.
The New England Journal of Medicine (2009)
Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure
Milton Packer;Philip A. Poole-Wilson;Paul W. Armstrong;John G. F. Cleland.
Wasting as independent risk factor for mortality in chronic heart failure.
Stefan D. Anker;Stefan D. Anker;Piotr Ponikowski;Susan Varney;Tuan Peng Chua.
The Lancet (1997)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: